Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study
Titel:
Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study
Auteur:
Schuler, A. Huser, J. Schmid, S. Schär, S. Scherz, A. Gautschi, O. Mauti, L. von Briel, T. Waibel, C. Wannesson, L. Pankovics, J. Mark, M.T. Rothschild, S.I. Addeo, A. Janthur, W.D. Siano, M. Boos, L. Britschgi, C. Früh, M.